You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Depakote ER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Depakote Er, and what generic alternatives are available?

Depakote Er is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in DEPAKOTE ER is divalproex sodium. There are eighteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the divalproex sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Depakote Er

A generic version of Depakote ER was approved as divalproex sodium by APOTEX on July 29th, 2008.

  Try a Trial

Drug patent expirations by year for Depakote ER
Drug Prices for Depakote ER

See drug prices for Depakote ER

Drug Sales Revenue Trends for Depakote ER

See drug sales revenues for Depakote ER

Recent Clinical Trials for Depakote ER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Virginia Commonwealth UniversityPhase 1/Phase 2
Puma Biotechnology, Inc.Phase 1/Phase 2
Barretos Cancer HospitalEarly Phase 1

See all Depakote ER clinical trials

Paragraph IV (Patent) Challenges for DEPAKOTE ER
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
DEPAKOTE ER Extended-release Tablets divalproex sodium 500 mg 021168 2005-02-08
DEPAKOTE ER Extended-release Tablets divalproex sodium 250 mg 021168 2004-05-03

US Patents and Regulatory Information for Depakote ER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie DEPAKOTE ER divalproex sodium TABLET, EXTENDED RELEASE;ORAL 021168-002 May 31, 2002 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Abbvie DEPAKOTE ER divalproex sodium TABLET, EXTENDED RELEASE;ORAL 021168-001 Aug 4, 2000 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Depakote ER

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie DEPAKOTE ER divalproex sodium TABLET, EXTENDED RELEASE;ORAL 021168-001 Aug 4, 2000 ⤷  Try a Trial ⤷  Try a Trial
Abbvie DEPAKOTE ER divalproex sodium TABLET, EXTENDED RELEASE;ORAL 021168-001 Aug 4, 2000 ⤷  Try a Trial ⤷  Try a Trial
Abbvie DEPAKOTE ER divalproex sodium TABLET, EXTENDED RELEASE;ORAL 021168-002 May 31, 2002 ⤷  Try a Trial ⤷  Try a Trial
Abbvie DEPAKOTE ER divalproex sodium TABLET, EXTENDED RELEASE;ORAL 021168-001 Aug 4, 2000 ⤷  Try a Trial ⤷  Try a Trial
Abbvie DEPAKOTE ER divalproex sodium TABLET, EXTENDED RELEASE;ORAL 021168-001 Aug 4, 2000 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for Depakote ER

See the table below for patents covering Depakote ER around the world.

Country Patent Number Title Estimated Expiration
Italy 8024207 ⤷  Try a Trial
Argentina 021443 FORMULACION DE LIBERACION CONTROLADA DE DIVALPROEX SODIO ⤷  Try a Trial
Czech Republic 20012201 ⤷  Try a Trial
Canada 2330480 PREPARATION A LIBERATION CONTROLEE DE DIVALPROEX SODIUM (CONTROLLED RELEASE FORMULATION OF DIVALPROEX SODIUM) ⤷  Try a Trial
Slovenia 20624 Formulacija divalproeks natrija za kontrolirano sproščanje (CONTROLLED RELEASE FORMULATION OF DIVALPROEX SODIUM) ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.